Received May 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y015027 | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y013565 | — |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | UNK | X026480 | — |
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | X022827 | — |
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 2032352 | — |
No additional AE; a potential adverse event regarding improperly stored and administered vaccines: ROTATEQ, VAQTA, GARDASIL 9, VAXNUEVANCE, PNEUMOVAX 23.; This spontaneous report was received from medical assistant and refers to multiple patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On May-2025, the patient was vaccinated with improperly stored and administered vaccines, which underwent temperature excursion on 07-MAY-2025: Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (valid lot #Y013565, expiration date: 01-Feb-2027) 0.5 mL (Two or Three dose series), with Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE) (valid lot #X026480, expiration date: 12-Jan-2026) 0.5 mL (Four dose series); with Hepatitis A Vaccine, Inactivated (VAQTA) (valid lot #Y015027, expiration date: 06-Feb-2026) 0.5 mL (Two dose series), with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23), (valid lot #X022827, expiration date: 14-Aug-2025) 0.5 mL (once) with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), (valid lot #2032352, expiration date: 21-Oct-2025) 2 mL (three dose series) (product storage error). All suspect vaccines were administrated as prophylaxis. No additional information provided. No additional adverse event (AE) was reported. The case was considered as non-valid due to multiple patients without identifiers.